Clik here to view.
Preventing, treating COVID-19 infection
The U.S. continues to see new cases of COVID-19 infection, according to data provided by the Centers for Disease Control and Prevention. "The No. 1 strategy to prevent infection of the virus from...
View ArticleClik here to view.
12-6-21 Media Only News Briefing: COVID-19 treatments and therapeutics for...
On Monday, December 6, 2021 Mayo Clinic’s leading experts on COVID-19 treatments and therapeutics. Dr. Andrew Badley and Dr. Raymund Razonable discussed the new antiviral pills for the treatment of...
View ArticleClik here to view.
What’s the latest on monoclonal antibody therapies to treat COVID-19?
As COVID-19 continues to evolve and mutate quickly, so do treatment options. While the best ways to prevent the spread of COVID-19 are vaccinations and booster vaccinations, several authorized...
View ArticleClik here to view.
Mayo Clinic Q and A: Ways patients who are immunocompromised can protect...
DEAR MAYO CLINIC: My husband had a kidney transplant last year. The medication he takes to prevent organ rejection also suppresses his immune response, making him immunocompromised. I am concerned...
View ArticleClik here to view.
Mayo Clinic Q and A: COVID-19 treatment options
DEAR MAYO CLINIC: My cousin was diagnosed with COVID-19 last summer and received monoclonal antibody therapy. Another one of my cousins recently was diagnosed with COVID-19 but did not get that...
View ArticleClik here to view.
What experts know about COVID-19 omicron subvariant BA.2
ROCHESTER, Minn. — The World Health Organization designated COVID-19 variant B.1.1.529, named omicron, a "variant of concern" on Nov. 26, 2021, and the first confirmed case in the U.S. was on Dec. 1,...
View ArticleClik here to view.
Study finds few COVID-19 patients get rebound symptoms after Paxlovid treatment
ROCHESTER, Minn. — Mayo Clinic researchers studied the outcomes of 483 high-risk patients treated for COVID-19 with a five-day oral regimen of nirmatrelvir and ritonavir, together marketed as...
View ArticleClik here to view.
Patients treated with monoclonal antibodies during COVID-19 delta surge had...
ROCHESTER, Minn. — A study of 10,775 high-risk adult patients during the COVID-19 delta variant surge in late 2021 finds that treatment with one of three anti-spike neutralizing monoclonal antibodies...
View ArticleClik here to view.
Mayo Clinic research shows bebtelovimab to be a reliable option for treating...
ROCHESTER, Minn. — Mayo Clinic researchers say the monoclonal antibody bebtelovimab, already authorized by the Food and Drug Administration for emergency use on the omicron variant of COVID-19, is a...
View ArticleClik here to view.
Expert Alert: 5 ways patients who are immunocompromised can protect...
ROCHESTER, Minn. — As families prepare to gather later this month for Thanksgiving, it is important for patients who are immunocompromised to take extra steps to protect themselves from becoming...
View Article
